Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of ...

Notably, only 4.5% of participants reported accessing biosimilar information through patient education programs or from other healthcare providers such as pharmacists and nurses. Among those who had ...

Alvotech prioritizes maximizing biosimilar HUMIRA’s penetration in U.S. and ... I have a question around interchangeability. Could you compare and contrast the interchangeability and how ...

Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference ...

By comparison, Sandoz took 26 months to complete the same phase, according to the US data company. Celltrion markets Yuflyma, a biosimilar of Humira, in Europe, the US and Japan For biosimilars ...

The company announced that at week 16, more than 83% of patients dosed with Ebglyss no longer required the use of concomitant therapies such as topical corticosteroids. Credit: Shutterstock / Kmpzzz.

The real spectacle is not a rivalry but the audience’s endless fascination with comparison. A viral tweet listing the biggest female album debuts on Spotify this decade has reignited discussions about ...

The VGChartz sales comparison series of articles are updated monthly and each one focuses on a different sales comparison using our estimated video game hardware figures. The charts include ...

Omlyclo is the first interchangeable biosimilar to omalizumab (Xolair; Genentech, Novartis). Omlyclo was approved to treat the same conditions as Xolair. The FDA approved Celltrion’s omalizumab ...

This falls in line with biosimilars in other chronic disease spaces, such as the insulin glargine and adalimumab markets, where a dual-pricing strategy is utilized. 5 1. FDA approves first ...

Our charts below show the latest figures, which are drawn from intelligence agencies, defence officials, independent researchers and open-source intelligence. Start with Ukraine. Data from ...